Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.7556
-0.0207 (-2.67%)
Apr 29, 2025, 4:00 PM EDT - Market closed

Palisade Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
355818-
Upgrade
Market Cap Growth
-16.56%-16.56%-31.77%-54.57%--
Upgrade
Enterprise Value
-6-3-9-54-
Upgrade
Last Close Price
0.761.658.8578.00975.00-
Upgrade
PS Ratio
--21.88---
Upgrade
PB Ratio
0.280.610.480.642.40-
Upgrade
P/TBV Ratio
0.440.610.480.642.40-
Upgrade
Debt / Equity Ratio
0.020.020.030.030.03-0.20
Upgrade
Asset Turnover
--0.02---
Upgrade
Quick Ratio
3.053.054.874.594.260.10
Upgrade
Current Ratio
3.243.245.154.894.610.11
Upgrade
Return on Equity (ROE)
-153.56%-153.56%-103.40%-143.72%-20012.03%-
Upgrade
Return on Assets (ROA)
-74.50%-74.50%-53.85%-67.69%-94.46%-161.72%
Upgrade
Return on Capital (ROIC)
-96.02%-96.02%-65.36%-93.60%-777.90%-
Upgrade
Earnings Yield
-434.60%-316.35%-224.87%-177.89%-150.84%-
Upgrade
FCF Yield
-367.03%-267.16%-203.61%-166.78%-83.72%-
Upgrade
Buyback Yield / Dilution
-210.62%-210.62%-677.03%-370.85%--
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q